The global hemodialysis market is anticipated to grow from a value of US$ 96.54 billion in 2023 to US$ 149.92 billion by the end of 2033, expanding at a CAGR of 4.5%. Dialysis is a procedure used to eliminate waste components from the blood, such as urea and creatinine, which are formed when the kidneys don’t function correctly. Dialysis is necessary for those with chronic kidney diseases. Hemodialysis involves pumping blood out of blood vessels, purifying it with a dialyzer, and then reintroducing it to the body through the vascular access. Hemodialysis dialysis is a method used to treat renal disorders

The market for hemodialysis is driven by several factors, including the growing prevalence of chronic kidney diseases (CKD) and ESRD, increasing healthcare expenditure, and technological advancements in hemodialysis equipment and products. Additionally, the rising geriatric population and the increasing incidence of diabetes and hypertension are contributing to the market growth

Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=Srep_id=8315

The market is also influenced by government regulations and policies related to healthcare and reimbursement. Governments around the world are implementing various initiatives to increase access to hemodialysis services and improve patient outcomes, which has further fueled the market growth

Key Takeaways from Market Study

• Global sales of hemodialysis products are expected to increase at a CAGR of 4.5% from 2023 to 2033.
• The hemodialysis market in China is predicted to expand at a high CAGR of 7% during the projected period.
• Worldwide demand for hemodialysis services is expected to rise at a CAGR of 5% during the next 10 years.
• The market in Canada is anticipated to evolve at a 4% CAGR during the forecast period.

Competitive Landscape

The market is anticipated to be driven by leading manufacturers’ efforts to produce specialized dialysis equipment as well as expanding alliances and collaboration among industry participants. Some of the key players in the hemodialysis market are collaborating with regional participants to expand their product offerings, and for that, they are constantly working on pricing trends, local supply chain management systems, and product quality standards.

Some New Developments

• For instance, after getting FDA marketing approval, Medtronic introduced its Carpediem Cardio-Renal Paediatric Dialysis Emergency Machine in the United States in December 2020. The Cincinnati Children’s Hospital Medical Center received the first machine.
• To answer the unmet technological needs of the rising dialysis sector, Diality invested roughly US$ 12.5 million in creating a portable hemodialysis device in October 2020.
• Fresenius Medical Care North America (FMCNA) and Livongo Health, Inc. entered into a ground-breaking partnership in October 2020 to enhance the quality of life and outcomes for individuals with end-stage chronic kidney disease by raising optimal dialysis starts and providing earlier analysis of transplantation and home dialysis options.